Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis

To assess the therapeutic response to brolucizumab and aflibercept by deep learning/OCT-based analysis of macular fluid volumes in neovascular age-related macular degeneration. In this post-hoc analysis of two phase III, randomised, multi-centre studies (HAWK/HARRIER), 1078 and 739 treatment-naive e...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Eye (London) Ročník 37; číslo 6; s. 1160 - 1169
Hlavní autori:	Schmidt-Erfurth, Ursula, Mulyukov, Zufar, Gerendas, Bianca S, Reiter, Gregor S, Lorand, Daniel, Weissgerber, Georges, Bogunović, Hrvoje
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Nature Publishing Group 01.04.2023
Predmet:	Acuity Age Angiogenesis Inhibitors - therapeutic use Animals Deep Learning Hawks Humans Intravitreal Injections Macular degeneration Monoclonal antibodies Ranibizumab - therapeutic use Retinal Detachment Subretinal Fluid Tomography, Optical Coherence Vascular Endothelial Growth Factor A Wet Macular Degeneration - drug therapy
ISSN:	0950-222X, 1476-5454, 1476-5454
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!